Elaine Mardis, PhD is co-Executive Director of the Steve and Cindy Rasmussen Institute for Genomic Medicine at Nationwide Children’s Hospital and holds the Rasmussen Nationwide Foundation Endowed Chair in Genomic Medicine. She also is Professor of Pediatrics at The Ohio State University College of Medicine. Dr. Mardis was previously on faculty at Washington University School of Medicine for 22 years, where she was named the Robert E. and Louise F. Dunn Distinguished Professor of Medicine. Dr. Mardis serves on the Supervisory Board of Qiagen N.V. and on the Board of Directors of Singular Genomics Systems, Inc. She is an internationally recognized expert in cancer genomics and immunogenomics, with over 430 published manuscripts. Her ongoing research interests lie in the integrated characterization of cancer genomes, defining DNA-based somatic and germline interactions and RNA-based pathways and immune microenvironments that lead to cancer onset and progression, with a focus on pediatric cancers and precision oncology. Dr. Mardis is the former President of the American Association for Cancer Research. In 2019 she was elected a Fellow of the American Association for Cancer Research and a member of the U.S. National Academy of Medicine.
Tuesday, 17 June 2025
Wednesday, 18 June 2025
Time |
Session |
|
09:20
10:55
|
-
Clonal evolution of cancer from initiation to metastasis in the mouse (REMOTE Presentation)
-
Proffered Paper: Pancreatic Cancer Initiation: Wnt Signalling and Cell Dormancy Enable Kras Mutant Cell Survival
EACR25-0647
EACR25-0647
-
PEDIA-BRAIN: Building a normal brain tissue development encyclopedia as a comparator for pediatric CNS malignancies
-
Proffered Paper: Dietary Histidine controls intestinal stem cell activity, providing a potential protective role against colorectal cancer
EACR25-0457
EACR25-0457
-
Somatic evolution in normal tissues and cancer risk
Auditorium VI+VII
|